secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001606498-23-000071
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos closes sale of Respiratory Health business to SunMed for $110M cash
--------------------------------------------------------------------------

- Divestiture of Avanos' Respiratory Health business closed Oct 2, 2023; $110M cash purchase price subject to adjustments for indebtedness, inventory, and chargebacks.
- Amendment adds Assumed Chargeback Liabilities definition; purchase price reduced by estimated chargeback amount with final adjustment by Oct 31, 2023.
- India-related assets transferred separately at $910,000 purchase price; India purchase agreement to be executed post-closing.
- Indemnification cap for India VAT losses set at $172,000; other amendments modify purchase price calculation and escrow details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/0001606498-23-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/avns-20231002.htm
  HTML page:      https://secwatch.observer/filing/0001606498-23-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer